Aft, Forsyth & Company, Inc. Zoetis Inc. Transaction History

Aft, Forsyth & Company, Inc.

$174 Million
Q1 2024

A detailed history of Aft, Forsyth & Company, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 3,336 shares of ZTS stock, worth $583,666. This represents 0.32% of its overall portfolio holdings.

Number of Shares

3,336

Previous 4,016 16.93%

Holding current value

$583,666

Previous $792,000 28.79%

% of portfolio

0.32%

Previous 0.5%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$165.67 - $199.94 $112,655 - $135,959	-680 Reduced 16.93%	3,336 $564,000
Q4 2023 Feb 09, 2024	SELL	$151.44 - $200.09 $30,288 - $40,018	-200 Reduced 4.74%	4,016 $792,000
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $14,484 - $16,760	-90 Reduced 2.09%	4,216 $726,000
Q1 2023 May 02, 2023	SELL	$145.48 - $175.02 $48,153 - $57,931	-331 Reduced 7.14%	4,306 $716,000
Q4 2022 Feb 13, 2023	SELL	$131.14 - $157.47 $32,522 - $39,052	-248 Reduced 5.08%	4,637 $679,000

Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $87,491 - $107,704	-590 Reduced 10.78%	4,885 $724,000
Q2 2022 Jul 28, 2022	SELL	$155.97 - $200.09 $7,798 - $10,004	-50 Reduced 0.9%	5,475 $941,000
Q4 2021 Feb 07, 2022	SELL	$193.69 - $247.03 $9,684 - $12,351	-50 Reduced 0.9%	5,525 $1.35 Million
Q3 2021 Nov 08, 2021	BUY	$189.29 - $209.69 $40,697 - $45,083	215 Added 4.01%	5,575 $1.08 Million
Q2 2021 Jul 15, 2021	BUY	$155.9 - $187.99 $42,093 - $50,757	270 Added 5.3%	5,360 $999,000
Q1 2021 May 04, 2021	BUY	$144.0 - $169.39 $3,600 - $4,234	25 Added 0.49%	5,090 $802,000
Q4 2020 Feb 09, 2021	BUY	$157.07 - $174.35 $85,603 - $95,020	545 Added 12.06%	5,065 $838,000
Q3 2020 Nov 05, 2020	SELL	$137.1 - $165.37 $6,169 - $7,441	-45 Reduced 0.99%	4,520 $747,000
Q2 2020 Aug 06, 2020	BUY	$111.92 - $142.53 $43,648 - $55,586	390 Added 9.34%	4,565 $626,000
Q1 2020 May 11, 2020	BUY	$92.66 - $144.94 $3,243 - $5,072	35 Added 0.85%	4,175 $491,000
Q4 2019 Feb 10, 2020	BUY	$116.25 - $133.25 $120,900 - $138,580	1,040 Added 33.55%	4,140 $548,000
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $348,967 - $398,133	3,100 New	3,100 $386,000
Q2 2019 Jul 29, 2019	SELL	$97.98 - $114.28 $278,753 - $325,126	-2,845 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$81.56 - $100.67 $4,893 - $6,040	60 Added 2.15%	2,845 $286,000
Q4 2018 Feb 05, 2019	BUY	$79.28 - $95.27 $634 - $762	8 Added 0.29%	2,785 $238,000
Q3 2018 Oct 26, 2018	BUY	$83.5 - $93.23 $6,262 - $6,992	75 Added 2.78%	2,777 $254,000
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $5,033 - $5,619	-63 Reduced 2.28%	2,702 $230,000
Q1 2018 May 14, 2018	BUY	$71.51 - $84.69 $197,725 - $234,167	2,765 New	2,765 $231,000

Others Institutions Holding ZTS

# of Institutions

1,860

Shares Held

416M

Call Options Held

1.13M

Put Options Held

1.81M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.

Account

Aft, Forsyth & Company, Inc. Zoetis Inc. Transaction History